Net Asset Value(s) - Weekly Estimate
21 November 2019
HIGHBRIDGE TACTICAL CREDIT FUND LIMITED
(Formerly Highbridge Multi-Strategy Fund Limited)
Weekly Estimated Net Asset Value
The Company announces the unaudited net asset value ("NAV") of an Ordinary Share (a "Share") in the capital of the Company as at 15 November 2019 (the "Valuation Point"):
The Company also announces cumulative performance as at the Valuation Point:
Week on Week
Month to Date
Year to Date
Company NAV Performance
The above estimated NAV of Shares and associated performance data have been calculated using information which, whilst being received from a reliable source, is itself estimated. This estimated NAV and the performance data are indicative only.
The liquidators of AllBlue Limited ("AB") and AllBlue Leveraged Feeder Limited ("ABL") have informed the Company that they will no longer provide net asset values for AB and ABL, save for the audited financial statements as at 31 July 2018. The audited financial statements as at 31 July 2018 of AB and ABL have been used to prepare this valuation, net of any subsequent distributions from AB and ABL received by the Company. The AB and ABL holdings represent significantly less than one per cent of the Company's NAV.
Note: Your attention is drawn to the Company's announcement of the results of its extraordinary general meetings held on 24 February and 21 October, 2016 and all subsequent announcements concerning the redemption and repurchase of shares and change of investment policy. Investors should be aware that the amount payable on a return of capital, whether on a winding-up of the Company or otherwise, may differ materially from this valuation.
Praxis Fund Services Limited
Tel: +44 (0) 1481 737 600
Katie Standley, J.P. Morgan Asset Management (UK)
Tel: 0207 134 6220
E&OE - in transmission
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.